Partner Sylvie Gallage-Alwis discusses how Toxic tort is developing even more negatively in France for businesses who are today the target of multiple disputes related to exposure to a substance or risk, in Le Monde du Droit.
Sylvie’s article was published in Le Monde du Droit, 11 May 2020, and can be found here.
Contrary to popular belief, American Toxic Tort exists in France and is developing even more negatively for businesses than across the Atlantic.
Sylvie discusses how companies are today the target of multiple disputes related to exposure to a substance or risk. She also addresses how the use of a suspected toxic substance gives rise to often uncontrollable litigation or threats of litigation that companies can only take seriously, like the one currently used in anxiety related to the potential development of Covid-19.
Sylvie Gallage-Alwis is one of the founding partners of the Paris office of Signature Litigation and heads its product liability practice. She is specialised in all cutting-edge complex disputes linked to products, namely product liability, product safety, toxic tort, mass litigation/class action, regulatory compliance, and environment.